Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control

Date:
March 17, 1999
Source:
University Of Pittsburgh Medical Center
Summary:
Using a patented gene vector developed by the University of Pittsburgh, a University of South Carolina-led research team is the first to show that gene therapy blocks certain pain responses in animals. This landmark study, which paves the road for future clinical research, is published in the March 16 issue of the Proceedings of the National Academy of Sciences.

PITTSBURGH, March 16 -- Using a patented gene vector developed by the University of Pittsburgh, a University of South Carolina-led research team is the first to show that gene therapy blocks certain pain responses in animals. This landmark study, which paves the road for future clinical research, is published in the March 16 issue of the Proceedings of the National Academy of Sciences.

"Our research results clearly show that pain-associated behaviors diminished in mice treated with a herpes virus containing a gene that triggers production of a pain-blocking protein," said Joseph Glorioso, Ph.D., developer of the gene vector and professor and chairman of the department of molecular genetics and biochemistry at the University of Pittsburgh. "Our vector continued to produce this protein up to seven weeks after it was introduced into these animals, suggesting that this therapy may provide long-term pain relief if used clinically," added Dr. Glorioso, who also directs the Pittsburgh Human Gene Therapy Center.

Steven Wilson, Ph.D., professor of pharmacology and physiology at the University of South Carolina, who initiated this project while on sabbatical at the University of Pittsburgh, led the research team. David C. Yeomans, Ph.D., of the University of Illinois at Chicago, designed and performed the experiments demonstrating production of the pain-blocking protein and its pain-preventing effects.

The research team expects that within several years this approach could be used broadly to treat debilitating pain associated with cancer, arthritis, angina and peripheral neuropathies. Currently, these problems are often treated with narcotic-based medications given systemically, which can cause generalized side effects such as mental confusion and lethargy. Moreover, they are potentially addictive and in some cases ineffective for complete relief of pain.

Specifically, Dr. Wilson's team found that the gene acted on C-type neurons, which transmit information felt as slow, burning pain by humans. This observation is particularly encouraging for future clinical applications, according to the investigators, because C-type neurons are thought to be the primary transmitters of chronic pain.

"The gene-vector-based therapy, in contrast to current pain control methods, is highly localized, and the release of the potentially pain-relieving substance is self-limiting because it is triggered only when the nerves encounter hyper-stimulation," added Dr. Wilson.

"Our engineered herpes virus used for this research is exceptionally well-suited to deliver genes for pain relief," according to Dr. Glorioso.

The herpes virus resides exclusively in neurons and does not integrate with the host cell's DNA, where it could potentially alter the function of other genes. Further, the herpes virus is capable of transporting large genes or multiple genes required to carry out biological processes, such as regulating insulin production for the treatment of diabetes or producing multiple hormones that protect neurons against the destructive effects of neuropathologic conditions, including chemotherapy-induced damage.

Experiment Details: In their experiments, the investigators used a gene for preproenkephalin. Once produced inside the body, this substance is enzymatically processed into opiate-like peptides known as enkephalins. The researchers placed the gene inside a herpes virus capable of establishing latency in the nervous system, a state where the viral genes are inactive while the enkephalin gene remains active. The researchers transferred the gene-containing virus to the paws of mice, where it naturally infected sensory neurons, including those that respond to noxious stimuli such as heat.

"These results are quite exciting, because we don't interfere with an animal?s ability to detect a noxious stimulant and react to danger," said Dr. Wilson. "Only when sensitivities to noxious stimuli are enhanced, a phenomenon that may be important in chronic pain states, does the gene therapy act, with the result that gene-treated animals respond more slowly to this hyper-stimulation than do untreated ones," he added.

For more information about the University of Pittsburgh's Human Gene Therapy Center, please access http://www.pitt.edu/~rsup/phgt.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control." ScienceDaily. ScienceDaily, 17 March 1999. <www.sciencedaily.com/releases/1999/03/990317060656.htm>.
University Of Pittsburgh Medical Center. (1999, March 17). University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1999/03/990317060656.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control." ScienceDaily. www.sciencedaily.com/releases/1999/03/990317060656.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins